Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trialsSmithers, L.; Gibson, R.; McPhee, A.; Makrides, M.
2022Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsGould, J.F.; Makrides, M.; Gibson, R.A.; Sullivan, T.R.; McPhee, A.J.; Anderson, P.J.; Best, K.P.; Sharp, M.; Cheong, J.L.Y.; Opie, G.F.; Travadi, J.; Bednarz, J.M.; Davis, P.G.; Simmer, K.; Doyle, L.W.; Collins, C.T.
2020Association of poor postnatal growth with neurodevelopmental impairment in infancy and childhood: comparing the fetus and the healthy preterm infant referencesCordova, E.G.; Cherkerzian, S.; Bell, K.; Joung, K.E.; Collins, C.T.; Makrides, M.; Gould, J.; Anderson, P.J.; Belfort, M.B.
2008Carbohydrate intake is the main determinant of growth in infants born <33 weeks' gestation when protein intake is adequateCollins, C.; Gibson, R.; Miller, J.; McPhee, A.; Willson, K.; Smithers, L.; Makrides, M.
2010Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trialSmithers, L.; Collins, C.; Simmonds, L.; Gibson, R.; McPhee, A.; Makrides, M.
2009Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: A randomized controlled trialMakrides, M.; Gibson, R.; McPhee, A.; Collins, C.; Davis, P.; Doyle, L.; Simmer, K.; Colditz, P.; Morris, S.; Smithers, L.; Willson, K.; Ryan, P.
2010Role of long-chain polyunsaturated fatty acids in neurodevelopment and growthMakrides, M.; Smithers, L.; Gibson, R.; Lucas, A.; Makrides, M.; Ziegler, E.E.